CD4 and tuberculosis: WHO guidelines recommend isoniazid preventive therapy [13] to reduce TB mortality risks in asymptomatic HIV patients with low CD4 counts [14,15] and co-trimoxazole prophylaxis for patients with CD4 counts below 350 cells/μl [16]; both isoniazid preventive therapy and co-trimoxazole prophylaxis could augment the simplified algorithm.